: French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU

No Comments
Uncategorized

Valneva’s Phase 3 trial will compare the immune response generated by its vaccine with that of the vaccine developed jointly by AstraZeneca and the University of Oxford

Valneva’s Phase 3 trial will compare the immune response generated by its vaccine with that of the vaccine developed jointly by AstraZeneca and the University of Oxford